| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Richard A Young is Director at CAMP and has filed Form 4s across 2 companies. Richard A Young's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $714K at current prices.
The biggest single holding is CAMP (~$714K) as Director. Net of sales, the CAMP filings show accumulation of 31,529 shares.
Richard A Young has 32 Form 4 filings on record from September 2016 to August 2026, across 2 companies: Director at Camp4 Therapeutics (CAMP), 2024–2026; Director at Syros Pharmaceuticals (SYRS), 2016–2024.
The 37 reported transactions were 17 open-market sales, 13 option or other derivative awards, 2 open-market purchases and 2 option exercises, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 2 purchases worth about $52K and 15 sales worth about $1.3M.
The largest open-market purchase was 16,378 shares of CAMP at an average $1.65 on August 3, 2026, about $27K.
The largest open-market sale was 25,000 shares of SYRS at an average $10.00 on August 16, 2019, about $250K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | CAMP Camp4 Therapeutics Corporation | Director | Buy | 16,378 | $1.65 | $27,023.70 | +9.6% | -7.4% | - | |
| Sep 11, 2025 | CAMP Camp4 Therapeutics Corp | Director | Buy | 15,151 | $1.65 | $24,999.15 | +9.8% | +105.8% | +52.9% | |
| Jun 28, 2024 | SYRS Syros Pharmaceuticals, Inc. | Director | Sell10b5-1 | 34,837 | $5.12 | $178,365.44 | -81.3% | - | - | |
| Feb 16, 2021 | SYRS Syros Pharmaceuticals, Inc. | Director | Sell | 3,750 | $12.05 | $45,187.50 | -1.2% | - | - | |
| Feb 8, 2021 | SYRS Syros Pharmaceuticals, Inc. | Director | Sell | 3,750 | $13.04 | $48,900.00 | -1.1% | - | - | |
| Nov 17, 2020 | SYRS Syros Pharmaceuticals, Inc. | Director | Sell | 5,990 | $8.77 | $52,558.09 | -1.7% | - | - | |
| Oct 19, 2020 | SYRS Syros Pharmaceuticals, Inc. | Director | Sell | 5,673 | $8.75 | $49,638.75 | -1.7% | - | - | |
| Oct 15, 2020 | SYRS Syros Pharmaceuticals, Inc. | Director | Sell | 317 | $8.75 | $2,773.75 | - | - | - | |
| Sep 15, 2020 | SYRS Syros Pharmaceuticals, Inc. | Director | Sell | 5,990 | $10.39 | $62,236.10 | -1.7% | - | - | |
| Aug 17, 2020 | SYRS Syros Pharmaceuticals, Inc. | Director | Sell | 5,990 | $12.59 | $75,414.10 | -1.7% | - | - |